These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 12883702

  • 1. Relationship between AgNORs, MIB-1 and oncogene expression in male breast carcinoma and papillary superficial bladder neoplasm.
    Pich A, Margaria E, Chiusa L, Bortolin P, Palestro G.
    Oncol Rep; 2003; 10(5):1329-35. PubMed ID: 12883702
    [Abstract] [Full Text] [Related]

  • 2. Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder.
    Pich A, Chiusa L, Formiconi A, Galliano D, Bortolin P, Comino A, Navone R.
    Cancer; 2002 Aug 15; 95(4):784-90. PubMed ID: 12209722
    [Abstract] [Full Text] [Related]

  • 3. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A, Posch B, El-Baz M, Mokhtar AA, Susani M, Ghoneim MA, Marberger M.
    J Urol; 2001 May 15; 165(5):1481-7. PubMed ID: 11342901
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Bcl-2 protein expression is associated with p27 and p53 protein expressions and MIB-1 counts in breast cancer.
    Tsutsui S, Yasuda K, Suzuki K, Takeuchi H, Nishizaki T, Higashi H, Era S.
    BMC Cancer; 2006 Jul 13; 6():187. PubMed ID: 16839413
    [Abstract] [Full Text] [Related]

  • 7. The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder.
    Popov Z, Hoznek A, Colombel M, Bastuji-Garin S, Lefrere-Belda MA, Bellot J, Abboh CC, Mazerolles C, Chopin DK.
    Cancer; 1997 Oct 15; 80(8):1472-81. PubMed ID: 9338472
    [Abstract] [Full Text] [Related]

  • 8. [Comparative study of P 53, Bcl-2, and C-erbB-2 expression in low-grade papillary bladder tumors].
    Ramos Soler D, Navarro Fos S, Villamón Fort R, Gil Salom M, Llombart Bosch A.
    Arch Esp Urol; 2003 Apr 15; 56(3):277-85. PubMed ID: 12768988
    [Abstract] [Full Text] [Related]

  • 9. Oncogenes and male breast carcinoma: c-erbB-2 and p53 coexpression predicts a poor survival.
    Pich A, Margaria E, Chiusa L.
    J Clin Oncol; 2000 Aug 15; 18(16):2948-56. PubMed ID: 10944127
    [Abstract] [Full Text] [Related]

  • 10. Proliferative status is a risk index for recurrence in primary superficial (pTa/T1) low-grade urothelial bladder carcinoma.
    Su JS, Arima K, Hasegawa M, Franco OE, Yanagawa M, Sugimura Y, Kawamura J.
    Hinyokika Kiyo; 2003 Nov 15; 49(11):649-58. PubMed ID: 14719452
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
    Klobusická M, Kusenda J, Babusíková O.
    Neoplasma; 2003 Nov 15; 50(6):408-15. PubMed ID: 14689061
    [Abstract] [Full Text] [Related]

  • 14. Oncogenes in male breast cancer.
    Idelevich E, Mozes M, Ben-Baruch N, Huszar M, Kruglikova A, Katsnelson R, Shani A.
    Am J Clin Oncol; 2003 Jun 15; 26(3):259-61. PubMed ID: 12796596
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Apoptosis in situ, p53, bcl-2 and AgNOR counts as prognostic factors in laryngeal carcinoma.
    Pulkkinen JO, Klemi P, Martikainen P, Grénman R.
    Anticancer Res; 1999 Jun 15; 19(1B):703-7. PubMed ID: 10216480
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa.
    Visca P, Alò PL, Del Nonno F, Botti C, Trombetta G, Marandino F, Filippi S, Di Tondo U, Donnorso RP.
    Clin Cancer Res; 1999 Dec 15; 5(12):4111-8. PubMed ID: 10632348
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
    Mitselou A, Ioachim E, Kitsou E, Vougiouklakis T, Zagorianakou N, Makrydimas G, Stefanaki S, Agnantis NJ.
    In Vivo; 2003 Dec 15; 17(5):469-77. PubMed ID: 14598611
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications.
    Popov Z, Gil-Diez-De-Medina S, Ravery V, Hoznek A, Bastuji-Garin S, Lefrere-Belda MA, Abbou CC, Chopin DK.
    Urol Oncol; 2004 Dec 15; 22(2):93-101. PubMed ID: 15082004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.